MedPath

Salutas Pharma GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

38

PHILIPPINES:25
NMPA:9
SFDA:4

Drug Approvals

Citalopram Hydrobromide Tablets

Product Name
氢溴酸西酞普兰片
Approval Number
J20171097
Approval Date
Dec 27, 2017
NMPA

Carvedilol Tablets

Product Name
卡维地洛片
Approval Number
H20170386
Approval Date
Nov 29, 2017
NMPA

Citalopram Hydrobromide Tablets

Product Name
氢溴酸西酞普兰片
Approval Number
H20171200
Approval Date
Oct 19, 2017
NMPA

Bisoprolol Fumarate Tablets

Product Name
富马酸比索洛尔片
Approval Number
J20171042
Approval Date
Aug 25, 2017
NMPA

Bisoprolol Fumarate Tablets

Product Name
富马酸比索洛尔片
Approval Number
国药准字J20171043
Approval Date
Aug 25, 2017
NMPA

Bisoprolol Fumarate Tablets

Product Name
富马酸比索洛尔片
Approval Number
J20171043
Approval Date
Aug 25, 2017
NMPA

Bisoprolol Fumarate Tablets

Product Name
富马酸比索洛尔片
Approval Number
国药准字J20171042
Approval Date
Aug 25, 2017
NMPA

Bisoprolol Fumarate Tablets

Product Name
富马酸比索洛尔片
Approval Number
H20170260
Approval Date
May 19, 2017
NMPA

Citalopram Hydrobromide Tablets

Product Name
氢溴酸西酞普兰片
Approval Number
H20160009
Approval Date
Jan 6, 2016
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.